Leigh Oliver

Leigh Oliver

January 05, 2015 | National Law Journal

Antitrust Enforcers Crack Down on 'Gun Jumpers'

Agencies worldwide challenge transactions for unlawful cooperation between parties prior to closing.

By Janet McDavid and Leigh Oliver

6 minute read

January 05, 2015 | National Law Journal

Antitrust Enforcers Crack Down on 'Gun Jumpers'

Agencies worldwide challenge transactions for unlawful cooperation between parties prior to closing.

By Janet McDavid and Leigh Oliver

6 minute read

August 15, 2012 | Inside Counsel

Supreme Court may decide whether “reverse payment” settlements violate antitrust law

Patent litigation in the pharmaceutical industry impacts billions of dollars in pharmaceutical sales annually.

By Leigh Oliver, Corey Roush, Logan Breed

9 minute read

June 29, 2012 | Inside Counsel

Supreme Court to determine whether state action doctrine can be used to circumvent antitrust laws

Despite losses at the district and appellate levels, the Federal Trade Commissions (FTC) fight to enjoin the merger of two hospitals in Albany, Georgia is not over.

By Leigh Oliver, Corey Roush, Logan Breed

4 minute read

June 04, 2012 | Inside Counsel

The benefits of “scrambling” merged eggs

After almost a year of review, the Federal Trade Commission (FTC) announced early on the morning of April 2 that it had closed its investigation of the proposed merger between two large pharmacy benefit managersExpress Scripts Inc. and Medco Health Solutions Inc.without taking any action.

By Corey Roush, Logan Breed, Leigh Oliver

12 minute read

May 02, 2012 | Inside Counsel

IP acquisitions and antitrust

Over the past several years, the technology industry has seen a sharp increase in patent-related litigation

By Logan Breed, Corey Roush, Leigh Oliver

12 minute read

April 02, 2012 | Inside Counsel

F.T.C. v. Graco Inc.: Widening the difference between merger challenges by the antitrust agencies

Practitioners and clients have long bemoaned the fact that a merger challenge by the Federal Trade Commission (FTC) is procedurally different than one by the Antitrust Division of the Department of Justice (DOJ) because the differences can have a substantive effect on the outcome of the merger challenge.

By Corey Roush, Logan Breed, Leigh Oliver

11 minute read

March 01, 2012 | Inside Counsel

FTC aggressively seeking to block provider consolidations while making way for ACOs

For the past several years, the Federal Trade Commission (FTC) and the Department of Justice Antitrust Division (DOJ) have acted aggressively to protect competition in the health care industry. For example, the FTC has filed complaints to enjoin three separate proposed hospital consolidations in the last year.

By Logan Breed, Corey Roush, Leigh Oliver

4 minute read